Among them, compared with patients in the SS group, the expressions of CXCL9 and CXCL10 in the livers of NASH patients further increased, while the CXCL11 expression only showed an increasing trend and did not reach statistical significance (Fig.
← all excerpts
Identification of the critical immune-related drivers shared by non-alcoholic fatty liver disease and osteoporosis.
1
—
—